Ignite Creation Date:
2025-12-24 @ 3:50 PM
Ignite Modification Date:
2026-01-12 @ 12:46 PM
Study NCT ID:
NCT03443492
Status:
COMPLETED
Last Update Posted:
2025-02-10
First Post:
2018-02-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SLOG Vs MFOLFIRINOX As the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer
Sponsor:
National Health Research Institutes, Taiwan
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
T5217
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None